
JD Health International, Inc. (6618) Receives a Buy from China Renaissance

China Renaissance analyst maintained a Buy rating on JD Health International, Inc. yesterday and set a price target of HK$93.29.TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off JD Health International, Inc. has an analyst consensus of Strong Buy, with a price target consensus of HK$75.59.
China Renaissance analyst maintained a Buy rating on JD Health International, Inc. yesterday and set a price target of HK$93.29.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
JD Health International, Inc. has an analyst consensus of Strong Buy, with a price target consensus of HK$75.59.

